DSM-Firmenich AG (LTS:0AC9) PEG Ratio: N/A (As of Jul. 06, 2026)


LTS:0AC9 DSM-Firmenich AG LTS:0AC9
50 GF Score
Price €83.69
GF Value €76.17
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is DSM-Firmenich AG PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, DSM-Firmenich AG's PE Ratio without NRI is 69.17. DSM-Firmenich AG's 5-Year EBITDA growth rate is 0.00%. Therefore, DSM-Firmenich AG's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for DSM-Firmenich AG's PEG Ratio or its related term are showing as below:



LTS:0AC9's PEG Ratio is not ranked *
in the Chemicals industry.
Industry Median: 2.29
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


DSM-Firmenich AG  (LTS:0AC9) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


DSM-Firmenich AG PEG Ratio Related Terms


DSM-Firmenich AG PEG Ratio Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG PEG Ratio Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
PEG Ratio
0.00 0.00 0.00 0.00

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PEG Ratio Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

LTS:0AC9 vs LIN, SHW, ECL: PEG Ratio Comparison

For the Specialty Chemicals subindustry, DSM-Firmenich AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DSM-Firmenich AG PEG Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's PEG Ratio distribution charts can be found below:

* The bar in red indicates where DSM-Firmenich AG's PEG Ratio falls into.


LTS:0AC9
50GF Score
DSM-Firmenich AG LTS:0AC9
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

DSM-Firmenich AG's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=69.165256198347/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is DSM-Firmenich AG (LTS:0AC9) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued. The current stock price of €83.69 is trading 9.9% above its estimated GF Value™ of €76.17. GuruFocus considers DSM-Firmenich AG to be Fairly Valued.

Key valuation signals for LTS:0AC9:

  • PEG Ratio: N/A
  • GF Value™: €76.17 vs. price of €83.69 (9.9% above fair value)
  • GF Score™: 50/100 with 8 warning signs

No single metric tells the full story. See the LTS:0AC9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
50GF Score

Get the complete analysis for LTS:0AC9

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.69
Price
€76.17
GF Value